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The objectives of this study were to determine what effects iodixanol would have on total and 
progressive motility, plasma membrane integrity (viability), acrosome integrity and DNA structure  
when present during cryopreservation of equine spermatozoa,. We hypothesized that the addition 
of iodixanol would improve post-thaw values for measured parameters. Ejaculates from six stallions 
were collected, centrifuged at 900 x g for ten minutes to remove supernatant, and suspended to 
200 x 106 cells/ml with 0%, 2.5% and 5% iodixanol in an egg-yolk based extender and 
cryopreserved. Before and after cryopreservation sperm motility was assessed by computer 
assisted semen analysis, and samples were stained with SYBR-14/propidium iodide (PI) for viability, 
with PI/fluorescent isothiocynate-PNA (Arachis Hypogaea) for acrosome integrity and assessed by 
flow cytometry. Sperm DNA was evaluated using the sperm chromatin structure assay test and 
assessed by flow cytometry. The mean (± S.E.) percentage pre- and post-thaw total motility, 
progressive motility, viability, acrosome reactivity, COMPαt and MEANαt were analyzed using 
Shapiro-Wilk test to evaluate if data followed a normal distribution. When results followed a 
normal distribution an ANOVA was performed and where a significant interaction of treatment 
was observed (p=0.05), a Tukey-Kramer post-hoc test was applied. If results did not follow a 
normal distribution, a binomial logistical regression was performed. The 5% post-thaw 
treatment group showed increased viability and decreased DNA damage (p<0.001). Although 
the 0% group showed greater total and progressive motility than the 2.5% group, it was not 
greater than the 5% group. The 5% post-thaw treatment group had significantly more (p<0.001) 
non-reacted and damaged acrosomes than both the 0% and 2.5% groups. These findings 
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suggest that the presence of iodixanol during cryopreservation may have a beneficial effect by 





















The goal of spermatozoal cryopreservation is the ability to preserve sperm with no 
negative effects of processing; and the sperm would perform, when thawed, just as well as it 
would have if it was never frozen. The first reported pregnancy using cryopreserved stallion 
epididymal spermatozoa was in 1957, using epididymal sperm, used whole milk with 10% 
glycerol as a freezing extender (Barker & Gandier, 1957). In this study, seven mares were 
artificially inseminated and one subsequently foaled: a 14.29% pregnancy rate. Since then, the 
expected pregnancy rate of frozen semen now ranges from 38% to 73% (Metcalf, 1995, Nielsen 
et al., 2008), with a mean of 40% to 45% (Vidament, 2005). This is not a large improvement for 
such a long time span, when compared to equine oocyte collection and transfer, which had its 
first reported pregnancy to term in 1988 by McKinnon (1/15, 7% foaling rate). By 1995 a 
pregnancy to term rate of up to 95% has been reported (Carnevale and Ginther, 1998).  
This slow advancement in the technique of spermatozoal cryopreservation is surprising, 
since breeding with frozen semen is now a routine insemination technique practiced world-
wide. This may be due to underfunding, as many breed registries prohibit its use, and also to 
the low pregnancy rates obtained. However by 1985, up to 32,000 mares were bred in three 
provinces in China, with a pregnancy rate of 68% (Amann & Pickett, 1987). In recent years, large 
breed registries, particularly the American Quarter, American Paint Horse and the Arabian, 
have allowed the use of frozen semen based on its advantages including not requiring the 
shipping of mares to breeding farms; the coordination of chilled semen request in anticipation 
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of ovulation; the long-term storage of semen of competing, injured or dead stallions; and the 
ability to transport semen internationally.  
In stallions, sperm motion characteristics are lowered after storage with high 
concentrations of seminal plasma, and the lowering of seminal plasma concentrations is 
beneficial to motility (Jasko et al., 1991). An important step in cryopreservation is reducing 
seminal plasma concentration, and is performed by the centrifugation of spermatozoa and the 
subsequent removal of the seminal plasma supernatant. Industry standard centrifugation 
forces are typically 400-600 x g. A sperm cushion can be added to allow increased 
centrifugation forces and to obtain increased spermatozoal recovery rates. Reported recovery 
rates with an iodixanol based cushion medium ranged from 81% to 107% (Ecot et al., 2005) 
after centrifugation for 20 minutes at 1000 x g. The complete recovery of the entire iodixanol 
cushion is a difficult procedure; the cushion media must be removed without disrupting or 
losing any of the soft pellet.  As a result, erring on the side of caution, the cushion is frequently 
incompletely removed and iodixanol residues are left remaining with the pellet. Sargusty et al., 
(2009) examined what the effects of these residues could be if iodixanol was added to a bovine 
freezing extender (Andromed®). The presence of 1.25%, 2.5% and 5% iodixanol (Optiprep™, 
v/v) during freezing was associated with improved semen longevity and acrosomal viability. To 
date no similar study has been performed with equine spermatozoa. 
The objective of this study was to evaluate the effect of 0%, 2.5% and 5% iodixanol 
(Optiprep™ (v/v)), in an egg yolk and glycerol based freezing extender (EZ Freezin LE, Animal 
Reproduction Services, Chino, CA), on equine spermatozoal total and progressive motility, 






2.1. Stallion Sperm Structure  
 The equine spermatozoon can be divided into a head, neck, middle piece, principal 
piece and end piece, and is completely surrounded by a continuous and fluid plasma 
membrane. The spermatozoal head contains the nucleus, acrosome and cytoplasm. The 
nucleus occupies the majority of the spermatozoal head space, and contains highly condensed 
chromatin. This tight condensation of nuclear material is due to establishment of intra- and 
inter-molecular disulfide linkages that result in compaction and stabilization of the DNA (Varner 
and Johnson, 2007).  These bonds are formed during passage of the spermatozoa through the 
epididymis, and are believed to occur as the compacted state offers protection during 
spermatozoal movement prior to fertilization. The nucleus is surrounded by a nuclear envelope, 
which is a double membrane separating the nucleus from the surrounding cytoplasm. 
 The acrosome is an exocytotic organelle, covering the rostral two-thirds of the nucleus. 
It is a membrane bound structure, with connected inner and outer acrosomal membranes, 
enclosing an acrosomal matrix composed of hydrolytic enzymes (hyaluronidase, 
proacrosin/acrosin and lipases) (Varner and Johnson, 2007). During the acrosome reaction, the 
outer acrosomal membrane and the spermatozoal plasma membrane fuse, resulting in 
exocytotic release of the enzymes and exposure of the binding receptors. The remainder of the 
spermatozoal head is composed of cytoplasm, containing few organelles and mostly contains 
cytoskeletal proteins that are important for spermatozoal form and function (e.g. anchoring the 
acrosome to the underlying nuclear envelope; Varner and Johnson, 2007).  
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 The neck and tail (composed of the middle piece, principal piece and end piece) 
comprise the rest of the sperm. The neck is the connecting piece between the head and the 
middle piece and consists of the capitulum, segmented columns and the proximal and distal 
centrioles (Varner and Johnson, 2007). The proximal centriole remains present in the mature 
spermatozoa and is the site where the tail beat is initiated. The distal centriole develops into 
the axoneme during spermatozoal tail development. The middle piece contains numerous 
mitochondria overlying the dense fibers and the axoneme. Mitochondria are helicoidally 
arranged in a continuous double spiral, and produce ATP required for flagellar movement 
(Varner and Johnson, 2007).  
The principal piece is composed of the axoneme, which is continued from the middle 
piece and terminates in the caudal principal piece, and the fibrous sheath. The axoneme is a 
cylindrical array of nine doublet microtubules that surround two singlet microtubules (termed 
the central pair) connected by regularly spaced bridges, thus forming the characteristic ‘9+2’ 
configuration. The outer fibrous sheath provides structural support and flexibility to the 
flagellum (Varner and Johnson, 2007).  
 The equine spermatozoal plasma membrane is the outer most component and 
completely encompasses the entire cell and is composed of lipids and proteins (Flesch and 
Gadalla, 2000), and how spermatozoa respond to a decrease in environmental temperature is a 
direct measure of how the lipid and protein components of the membrane alter in response to 
decreasing temperatures. As temperature decreases, sperm membrane destabilization occurs 
when the membrane undergoes a phase transition from the fluid phase to the gel phase. Due 
to the loss of most cell organelles and DNA transcription ability during spermatogenesis, 
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spermatozoa lack vesicular transport. As a result the plasma membrane is a stable and inert 
structure, and plasma membrane components (protein, phospholipids and cholesterol) cannot 
be synthesized de novo (Flesch and Gadella, 2000). The plasma membrane is composed of 
three zones: lipid bilayer, phospholipid-water interface, and glycocalyx (Amann and Graham, 
2010).  
The lipid bilayer is composed of polar phospholipids, with hydrophobic fatty acyl chains 
directed internally and the hydrophilic, charged polar head groups directed externally. The 
plasma membrane lipids mostly consist of phospholipids and cholesterol; other lipids present 
include neutral lipids and glycolipids; however, phospholipids comprise up to 70% of all lipids 
present (Flesch and Gadella, 2000). Also present in the plasma membrane are proteins that are 
classified as either integral or peripheral proteins. Proteins account for up to 50% of the plasma 
membrane weight (Amann and Pickett, 1987). The integral proteins serve as pores or channels 
through the membranes or as receptors for ligands. The peripheral proteins are attached to the 
plasma membrane by electrostatic forces. Many of the integral and peripheral proteins contain 
carbohydrate side chains and extend some distance from the lipid bilayer (Amann and Pickett, 
1987).  The carbohydrate side chains have a net negative charge and attract and loosely bind 
other proteins or glycoproteins, resulting in the outer surface of the plasma membrane having a 
transient covering of material that is dependent on its surrounding environment.  The 
cholesterol to phospholipid molar ratio in the plasma membrane of stallion spermatozoa is 
0.36, which is midway between the values for boar (0.26) and bull (0.45) spermatozoa (Parks 
and Lynch, 1992). The plasma membrane is in a fluid state at body temperature, allowing 
phospholipids to move freely, resulting in differences in phospholipid distribution throughout 
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the membrane. The ratio of cholesterol to phospholipids with polyunsaturated acyl side chains 
will determine the fluidity of the membrane, with higher levels of cholesterol associated with 
better membrane decreased fluidity but better stability during cooling (Amann and Pickett, 
1987). 
2.2. Stallion Sperm Cryopreservation 
 It is estimated that 20% of stallions produce semen that freezes well, 60% freeze 
acceptably and 20% freeze badly (Vidament et al., 1997). When compared to the bull, stallions 
are considered poor freezers, and the reason for this is not completely understood. Bulls have 
been selected by the AI industry for many years based on the ability of their spermatozoa to 
withstand the stress of standard cryopreservation protocols; no such selection process exists 
for stallions (Loomis & Graham, 2008). Some reasons postulated to explain the poor freezability 
of equine spermatozoa include the unique cell size and shape of equine spermatozoa, the 
osmotic tolerance of sperm, the chemical composition of sperm, and the selection of stallions 
based on athletic traits and not reproductive parameters (Amann & Pickett 1987, Squires 2005, 
Loomis & Graham 2008). 
There is no single standardized equine semen cryopreservation protocol. Samper and 
Morris (1998) surveyed 21 world-wide laboratories that were involved in the freezing of semen 
for commercial purposes. Their survey included many questions covering all aspects of 
cryopreservation, including; the number of ejaculates collected to deplete extra-gonadal 
reserves prior to the first freeze; the number of test-freeze extenders used; dilution ratio and 
centrifugation protocol after collection; type of freezing extender used; type of antibiotics used; 
equilibration of semen before cryopreservation; freezing concentration; freezing and thawing 
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procedure; post-thaw evaluation criteria; insemination recommendations; acceptable first cycle 
pregnancy rate; and what the laboratory thought was the single most important factor when 
freezing stallion spermatozoa.  Each of the questions had more than one answer, 
demonstrating that none of the researchers agreed on any single parameter. It has been 
suggested a standard protocol should consist of two-step dilution procedure, in which the gel-
free ejaculate is either diluted 1:1 or to 50 x 106 spermatozoa/ml with a centrifugation 
extender, extended semen centrifuged for 10-15 minutes at 400-600g, the supernatant 
(consisting of the centrifugation extender and seminal plasma)removed, re-extension of the 
spermatozoal pellet with freezing extender to the desired freezing concentration, packaging 
into 0.5-ml or 5-ml straws, cooling from room temperature to +5°C, freezing in either liquid 
nitrogen vapor or in an automated freezing chamber, and storage in liquid nitrogen (Sieme 
2010). 
 Similarly, there is no single standard equine freezing extender. Samper and Morris 
(1998) reported four different freezing extenders that were being used by the surveyed 
laboratories. Despite the difference in extenders being used, all laboratories combined a source 
of energy (sugars), a source of lipoproteins to facilitate protection against rapid cooling (e.g. 
milk, egg yolk, or a combination of both), antibiotics to inhibit bacterial growth, buffers to 
balance pH, and a cryoprotectant. Cryoprotectants can be divided into permeable and 
impermeable categories (Sieme et al., 2008). The permeable agents act as both a solvent and 
solute and their presence will result in a higher concentration of water remaining unfrozen at 
lower temperatures, which protects the cells by minimizing the time of exposure to critical salt 
concentrations (Amann and Pickett, 1987, Sieme et al., 2008). Permeable cryoprotectants 
8 
 
include dimethyl sulfoxide, amides (methyl formamide and dimethyl formamide) and alcohols 
(ethylene glycol and glycerol). Impermeable agents act solely as a solute (Loomis and Graham, 
2008). Their mode of action includes protecting cells against rapid cooling, stabilizing the 
plasma membrane, and by raising the percentage of unfrozen water at a given temperature 
(Amann and Pickett, 1987, Sieme et al., 2008). Impermeable protectants include sugars 
(lactose, mannose, raffinose), amino acids (glutamine and proline), proteins and lipids.  
Glycerol is the most widely used permeating cryoprotectant used for the 
cryopreservation of equine spermatozoa, and recommended concentrations are 2.5% to 3.5%, 
although concentrations up to 10% glycerol have been reported (Samper and Morris, 1998). 
Glycerol can exert both osmotic and chemical toxic effects. Spermatozoa are subjected to a 
transient osmotic stress, as glycerol and extender ingredients equilibrates across the plasma 
membrane, resulting in temporary spermatozoal dehydration and reduced cell volume. The 
chemical toxic effects of glycerol exposure include protein denaturation, alteration of actin 
interactions and induction of protein free membrane blisters (Alvaranga et al., 2005). 
Alternatives to glycerol that possess a shorter period of equilibration have been investigated 
(Squires et al., 2004). In this study a 0.55 M glycerol was compared to 0.3, 0.6 and 0.9 M methyl 
formamide and dimethyl formamide, smaller amide molecules, and it was demonstrated that 
0.6 and 0.9 M preparations of  both methyl formamide and dimethyl formamide had a post-
thaw total motility statistically similar to the glycerol treatment (P<0.05). The results of this 
study suggest that these amides are acceptable alternatives to glycerol. 
 Lipid based cryoprotectants, sourced from egg-yolk and milk, are a common component 
of freezing extenders, although the exact mechanism of cryoprotective action of lipids during 
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cryopreservation is unclear; it is most likely caused by the low density lipoproteins (LDL) they 
contain; proposed mechanisms of action include reversible binding to extracellular lipids in 
stallion seminal plasma and fusion to the spermatozoal membrane (Ricker et al., 2006). In the 
bull, seminal plasma proteins can cause cholesterol and phospholipid efflux from the 
spermatozoal plasma membrane and the addition of low density lipoproteins resulted in a 
phospholipid and cholesterol gain by the plasma membrane, which resulted in greater 
protection of spermatozoa during cooling and cryopreservation (Bergeron et al., 2004). An 
animal-free source of lipids is soybean lecithin. When used to freeze bull spermatozoa, a 
soybean lecithin-based extender was shown to have a significantly higher post-thaw motility 
and non-return rate when compared to an egg yolk-based freezing extender (Aires et al., 2003). 
A soybean lecithin-based extender has recently become commercially available for the stallion 
(Andromed-E™; Minitüb, Wisconsin).                                 
2.3. Spermatozoal Response to Cooling 
       Rapid cooling of equine spermatozoa from 20 °C to 5 °C induces a partially 
irreversible damage, which is characterized by abnormal motility, loss of motility, damage to 
the plasma and acrosome membranes and reduced metabolism, and is aptly referred to as 
cold-shock (Amann and Pickett, 1987). Watson et al., (1987) demonstrated that cold shock 
damaged both the acrosomal and plasma membranes after rapidly lowering spermatozoal 
temperature from 30 °C to 0 to 4 °C (Table 2.1). Ideally, the cooling rate of animal spermatozoa 





Table 2.1 Percentage of spermatozoa with damaged head membranes after various degrees of 




30 °C 16 °C 8 °C 4 °C 0 °C 
Intact Plasma & Acrosome 
Membrane (%) 
81 66 63 44 29 
Damaged Plasma & Intact Acrosome 
Membrane (%) 
9 10 12 23 41 
Damaged Plasma & Acrosome 
Membrane (%) 
11 16 20 25 42 
  
When spermatozoa are cooled, the lipids undergo a phase transition from a liquid state 
into a gel or solid state, as cooling changes the shape of phospholipids. During membrane 
transition there is straightening and lengthening of fatty acyl chains which allow phospholipids 
to become tightly packed, and this process results in the aggregation or exclusion of proteins 
(Quinn, 1985). Each phospholipid undergoes this phase transition at a different temperature 
because there are many different acyl fatty chains present, with longer chains transitioning first 
at a higher temperature, which occurs at 19 °C for stallion spermatozoa (Hammerstedt et al., 
1990). As the temperature drops further, more lipids undergo transition and further coalescing 
occurs. The range of temperature over which phospholipid transition occurs is 20 or 30 °C, and 
after the change to the gel or crystalline state phospholipids can no longer move in a random 
fashion (Amann and Pickett, 1987). Coalescence of membrane phospholipids is a change from 
the lamellar arrangement to a hexagonal-II form, which is a circular arrangement of 
phospholipids, with the hydrophilic head groups facing out. This change in arrangement is due 
to a change in shape of the fatty acyl chains due to cold exposure. Coalescence of membrane 
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lipids causes increased membrane permeability, as hydrophilic channels are created between 
the outer surface of the hexagonal-II forms and the surrounding phospholipid lamellar 
arrangement (Amann and Pickett, 1987). Finally, upon reaching the lowest transitioning 
temperature the entire membrane is in a gel state, and the membrane has lost its fluidity. The 
formation of the hexagonal-II form is reversible, with return to the normal bi-lamellar 
arrangement occurring upon warming; however this re-arrangement is an irreversible event for 
certain phospholipids leading to a loss of normal plasma membrane form and function (Quinn, 
1985).   
2.4. Spermatozoal Changes in Response to Cryopreservation 
Cryopreservation has been reported to cause further changes in spermatozoal plasma 
membrane structure as a response to decreasing temperatures, and those changes are similar 
to changes seen at capacitation, including elevated intra-cellular calcium, in preparation for 
acrosomal exocytosis (Watson, 2000). During capacitation there is an efflux of cholesterol from 
the plasma membrane. A similar cholesterol efflux has been reported in spermatozoa of boars 
(Maldjian et al., 2005) and bucks (Chakrabarty et al., 2007) after cryopreservation, both studies 
showed a reduction in plasma membrane cholesterol content and a positive correlation 
between decreasing plasma membrane cholesterol levels and an increased proportion of 
acrosome-reacted spermatozoa present after thawing, the latter being measure using 
fluorescent lectin PNA and propidium iodide (Maldjian et al., 2005). The presence of 
intramembranous cholesterol has a protective effect, as its presence during decreasing 
environmental temperature will block phospholipid coalescence, thus maintaining membrane 
fluidity. The addition of 1.4 mg/ml of cholesterol-loaded cyclodextrins (CLC) to egg-yolk diluents 
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has resulted in higher percentages of motile and viable cells of bull semen (Purdy and Graham, 
2004). In the stallion, the addition of 1.5 mg/ml to a freezing extender had a beneficial effect 
(Moore et al., 2005). In addition to the loss of cholesterol, both studies demonstrated a 
significant change from long chained polyunsaturated fatty acids to saturated fatty acids 
(Maldjian et al., 2005, Chakrabarty et al., 2007). This change may not be reversible, making the 
membrane more hydrophobic, which may be a protective mechanism for the cell. Chakrabarty 
et al., (2007) suggested that the presence of egg yolk and its close adherence to the plasma 
membrane may facilitate the uptake of exogenous saturated fatty acids by the spermatozoal 
plasma membrane. 
The cryopreservation process can cause irreversible damage to spermatozoa. There are 
four main causes of spermatozoal damage that occur during the cryopreservation process: ice 
formation; reactive oxygen species; osmotic stress; and apoptotic-like changes. 
 2.4.1 Ice Crystal Formation 
The “two factor hypothesis”, proposed by Mazur (1984) states that intracellular ice, 
formed when cells are cooled rapidly, kills cells by either chemical toxicity or osmotic stress, 
and by mechanical damage caused by the phase separation of solution and crystal growth. 
However, more recent spermatozoal-specific studies have demonstrated that intracellular ice 
formation is unlikely to occur at currently used cooling rates during cryopreservation, and that 
spermatozoal damage is not as a result of intracellular ice crystal formation (Morris, (2006); 
Morris et al., (2007)). Using cryo-scanning electron microscopy Morris et al., (2007) 
demonstrated no apparent ice crystal formation in stallion spermatozoa cooled at rates from 
0.3 to 3000 °C/min in the presence of a glycerol-based freezing extender. Similar studies in men 
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(Morris, 2006) have demonstrated that intracellular ice formation is not present when 
spermatozoa are rapidly cryopreserved at rates of up to 3000 °C/min. For semen packaged in 
0.5-ml straws, using a conventional extender, the cooling rate is approximately 60 °C/ min, 
when straws are suspended 4 cm above liquid nitrogen, in an enclosed container with a vapor 
temperature of 160 °C (Amann and Pickett, 1987, Watson, 2000).Previously mentioned studies 
concluded that the loss of spermatozoal viability during cryopreservation is most likely 
associated with accompanying extra-cellular osmotic pressure changes, during cooling and 
thawing, and not direct damage caused by intra-cellular ice crystal formation.  
2.4.2. Osmotic Stress 
Specific steps of cryopreservation expose spermatozoa to periods of hypo- and 
hyperosmotic extra-cellular environments. Initially the addition of spermatozoa to a hyper-
osmotic freezing extender will result in a period of cellular dehydration as water and permeable 
cryoprotectants (e.g. glycerol) equilibrate across the plasma membrane. The length of time 
required for equilibration is associated with the permeability of the intra-cellular 
cryoprotectant to equilibrate. A second period of osmotic stress occurs during thawing, 
spermatozoa still in thawed freezing extender are initially exposed to a hypo-osmotic 
environment created by melting ice crystals and as a result there is an increase in cell volume 
until solute concentration finally equilibrates.  
Stallion spermatozoal cell volume, motility and viability change in response to 
extracellular osmolality (Pommer et al., 2002).  Spermatozoal cell volumes change after 
exposure to hypo-osmotic fluid (75 and 150 mOsm/kg) and hyper-osmotic fluid (450, 600 and 
900 mOsm/kg), and all spermatozoa were able to recover initial cell volume upon return to iso-
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osmotic conditions (300 mOsm/kg). A change in spermatozoal total motility was observed, with 
a significant decrease in all hypo- and hyper-osmotic conditions, and only spermatozoa exposed 
to 450 mOsm/kg conditions were able to regain initial total motility. In addition it was 
demonstrated that spermatozoa returned to the control solution (300 mOsm/kg) from 75, 150 
and 900 mOsm/kg treatments showed significantly lower cell viability.  It has been suggested 
that this dramatic change in cell volume may produce damage in a number of sperm 
compartments, including plasma membrane and mitochondria (Pommer et al., 2002). 
 Altering the glycerol in the spermatozoal environment to improve cryoprotection will 
have detrimental effects on spermatozoal motility and viability. Ball & Vo, (2001) showed that 
when increasing concentrations of glycerol were used, there was a decrease in equine sperm 
motility.  In addition they demonstrated that spermatozoa equilibrated with glycerol and then 
abruptly returned to isosmetric conditions suffered a decrease in motility. When glycerol was 
used to increase osmolality, there was a decrease in viability above 1200 mOsm/kg. They also 
showed a significant decline in mitochondrial membrane potential after an abrupt return to 
isosmotic conditions. Interestingly there was no change in acrosomal-intact spermatozoa, 
despite the decrease in the number of viable spermatozoa. If after thawing, the glycerol-loaded 
spermatozoa are abruptly transferred to conditions exceeding their osmotic tolerance, loss of 
motility, viability and potentially cell lysis may result (Ball, 2008). Attempts to minimize osmotic 
stress during cryopreservation have included step-wise dilution of cryoprotectants (Wessel and 
Ball, 2004), evaluation of alternative more-permeable cryoprotectants to glycerol (Squires et 
al., 2004) and increasing membrane stability by incorporating cholesterol-loaded cyclodextrns 
(CLC) in freezing diluents (Squires, 2005). 
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 2.4.3. Reactive Oxygen Species 
Oxidative stress is an imbalance between the production of reactive oxygen species 
(ROS) and the cellular capacity to detoxify ROS or to repair the resulting damage. Reactive 
oxygen species are produced during normal oxidative metabolism (Ball, 2008), and 
cryopreservation will result in an excess production of ROS. Equine spermatozoa are more 
susceptible to oxidative stress than other species due the high concentration of unsaturated 
fatty acids present in cellular membranes (Squires, 2005). Reactive oxygen species are products 
derived from the reduction of diatomic oxygen (O2), and include radicals and other reactive 
products (Ball et al., 2001). Radicals are atomic or molecular species that have unpaired 
electrons in their orbits, making them unstable as they will be involved in cellular reactions in 
order to displace or share these electrons. Reactive oxygen species have an important role in 
spermatozoal capacitation, and an imbalance in either the production or degradation of ROS 
can adversely affect spermatozoal survival and function (Baumber et al. 2003, Ball, 2008).  
The superoxide anion (O2
-), the most common ROS produced by spermatozoa, is rapidly 
converted to hydrogen peroxide (H2O2) by the scavenger superoxide dismutase (O2
- + O2
- + 2H+ 
→ H2O2 + O2) (Ball et al. 2001). The superoxide anion increases in equine spermatozoa exposed 
to hypo and hyperosmotic extracellular conditions (Burnaugh et al. 2010). Hydrogen peroxide is 
more stable than O2
- and can more readily cross plasma membranes, and has been shown to be 
the major ROS responsible for human and equine spermatozoal injury (Aitken et al. 1992, 
Baumber et al. 2000). The other two common ROS scavengers described in semen are catalase 
(which catabolizes H2O2) and glutathione peroxidase system, which reduces H2O2 (Ball, 2008). 
Spermatozoa have limited endogenous sources of these scavengers and rely predominantly on 
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extracellular sources, namely seminal plasma (Varner and Johnson 2007). Since the presence of 
excess seminal plasma can be detrimental to spermatozoal longevity and cryopreservation and 
is commonly removed prior to cryopreservation (Moore et al., 2005), the removal of ROS 
scavengers leaves spermatozoa particularly vulnerable to ROS during cryopreservation.  
The production of ROS by equine spermatozoa is from either sperm-specific NADPH 
oxidase (NOX 5) present in the plasma membrane of the spermatozoal head or from 
spermatozoal mitochondria (Sabeur & Ball 2006, 2007). The generation of ROS by NOX 5 in the 
spermatozoal head may be a necessary step in the induction of capacitation, resulting in 
tyrosine phosphorylation (Baumber et al. 2003). In cryopreserved equine spermatozoa the 
principle source of ROS generation is due to electron leakage from the mitochondrial electron 
transport chain (Sabeur and Ball 2006). The leakage of electrons results in the formation of the 
superoxide ion, which is rapidly converted to of H2O2 by superoxide dismutase.  
 The generation of H2O2 by equine spermatozoa is five-fold greater in amount by cryo-
damaged spermatozoa compared to control spermatozoa (Ball et al., 2001). The iatrogenic 
generation of ROS has been demonstrated in spermatozoal samples, resulting in a decrease in 
spermatozoal motility, but not viability, acrosomal integrity or mitochondrial membrane 
potential (Baumber et al. 2000). The presence of catalase, but not superoxide dismutase, 
appeared to maintain normal motility when spermatozoa were exposed to oxidative stress, 
indicating that H2O2 was the main ROS responsible for the observed changes. This effect on 
motility by H2O2 has also been demonstrated in human spermatozoa, possibly caused by a 
decrease in ATP without a significant decrease in mitochondrial membrane potential 
(Armstrong et al. 1999). In a follow-up equine study, the presence of H2O2 and not superoxide 
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anion appears to be the ROS responsible for DNA fragmentation, but the exact mechanism of 
damage is undetermined (Baumber et al. 2003). Cryopreservation causes oxidative stress, and 
spermatozoal damage is caused by H2O2, whether spermatozoal damage is morphologically 
apparent or not. 
 2.4.4. Apoptotic-Like Changes 
 Apoptosis is defined as the process of programmed cell death that affects single cells 
and induces a series of cellular, morphological and biochemical alterations, leading to cell 
suicide, without any related inflammation in the surrounding tissue (Ameison 1996).  The 
initiation of apoptosis is caused by two distinctly different pathways, the intrinsic and extrinsic 
pathways. The intrinsic pathway in spermatozoa is activated by stress induced cell changes; 
these stresses include oxidative stress, osmotic stress, heat, hypoxia, DNA damage or lack of 
pro-survival factors (Ball et al., 2008, Glazer et al., 2009, Peña et al., 2011). These stressors 
result in activation of the mitochondrial-dependent pathway of apoptosis and subsequent 
mitochondrial release of cytochrome c, which activates caspases 3, 7, and 9, resulting in cell 
death. The extrinsic pathway is activated by plasma membrane receptor-ligand binding leading 
to activation of caspases. 
 Cryopreservation can cause apoptotic like changes to equine spermatozoa. A number of 
apoptotic like changes have been demonstrated in equine spermatozoa after cryopreservation 
including decreased mitochondrial membrane potential, altered membrane structure, caspase 
activation (Brum et al.,2008), and increased DNA fragmentation (Brum et al., 2008, Baumber et 
al., 2003).  Active caspases 3, 7, and 9 have been detected in sperm and are considered a 
measure of mitochondrial apoptotic changes (Ortega-Ferrusola et al., 2008). 
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2.5. Spermatozoal Evaluation 
2.5.1. Motility 
The evaluation of spermatozoal motility is considered one of the most important 
measures of spermatozoal quality. Poorly motile or immotile spermatozoa are considered 
incapable of fertilization without the help of assisted reproductive techniques. However 
spermatozoal motility alone should never be used to predict fertility, as there are many other 
requirements of spermatozoa for the fertilization of an oocyte. 
 Motility evaluation can be performed using light microscopy. A drop (5 to 10 µl) of raw 
or extended semen is placed on a pre-warmed microscope slide, covered with a coverslip, and 
the total and progressive motility at 100x, 200x or 400x magnification evaluated in four to six 
fields.  To overcome the subjectivity of microscopic evaluation, computer assisted sperm 
analysis (CASA) systems have been developed. This technique offers an objective and rapid 
method of motility analysis by recording 40 to 60 frames/second of spermatozoal movement 
(Baumber-Skaife, 2010). The recommended evaluation concentration is 25 to 40 x 106/ml 
(Varner et al., 1991). Characterization of motility is based on a number of defined parameters, 
including total motility (TM), progressive motility (PM), curvilinear velocity (VCL), average path 
velocity (VAP), straight line velocity (VSL), lateral head displacement (LHD), beat cross 
frequency (BCF), linearity (LIN), straightness (STR), wobble (WOB), and circularly motile 
spermatozoa (CIR). Using this technique variability is not totally eliminated as there is currently 
no universally accepted definitions or values for the above parameters, with some variation 




 2.5.2. Concentration 
Concentration evaluation of ejaculates is a fundamental part of semen evaluation and 
allows a calculation of total-sperm number. The current gold standard method of concentration 
measurement is the hemacytometer (Baimber-Skaife, 2010). The most commonly used design 
is the Neubauer hemacytometer. Other commonly used methods of concentration 
measurement include spectrophotometric analysis, and more recently developed 
NucleoCounter®SP-100™ (ChemoMetec A/S, Denmark), which utilizes the nucleic stain 
propidium iodide.  
To calculate concentration using a hemacytometer, raw semen a 1:100 dilution with 
formal buffered saline (FBS). The chamber space between the hemacytometer and coverslip is 
loaded on both sides of the hemocytometer, and then given time for the spermatozoa to settle. 
Using light microscopy at 400x, all the spermatozoal heads are counted within the 25 central 
squares. The counting of spermatozoa is repeated on the second grid, and the average numbers 
of spermatozoa present is calculated, which represents the sperm concentration in millions/ml. 
Possible sources of variation include difference in hemacytometer design and operator error. At 
least two chambers should be counted, with no greater than a 10% difference in spermatozoa 
counted between chambers. It is suggested that up to four chambers should be counted to help 
reduce error (Christensen et al., 2005). 
2.5.3. Morphology 
Spermatozoal morphology is an important component of semen evaluation. 
Abnormalities in spermatozoal shape can reflect abnormal spermatogenesis; these 
abnormalities may potentially affect spermatozoal fertilizing capacity (Baumber-Skaife, 2010). 
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Morphology is examined by phase contrast or differential interference contrast (DIC) 
microscopy, at 1000x oil immersion. This can be done by placing a drop (5 to 10µl) of raw 
semen diluted with formalin buffered saline (FBS) on a microscope slide, covered with a cover 
slip, and then examined under by microscopy. Alternative methods of evaluation include using 
background or cellular stains. At least 100 to 200 spermatozoa should be evaluated and 
morphological defects noted. Typical abnormalities noted include head shape, acrosome form, 
proximal or distal droplets, mid-piece abnormality, coiled and kinked tail, detached heads and 
round cells.  Spermatozoa can have more than one defect. It is also possible to induce 
morphological defects through poor sample preparation; iatrogenic abnormalities include 
reflected mid-pieces (cold-shock) and coiled tails (hypo-osmotic shock) (Baumber-Skaife, 2010). 
2.5.4. Plasma Membrane & Acrosome Integrity 
The assessment of spermatozoal viability using fluorescent probes uses a combination 
of two stains, one that will identify living cells and one that identifies non-viable (dead) cells. 
The level of staining can be assessed by fluorescent microscopy or flow cytometry. The 
combination of nucleic acid stains SYBR-14 and propidium iodide (PI) to assess spermatozoal 
viability was developed by Garner and Johnson (1995). These nucleic acid stains consist of one 
that is membrane permeate (SYBR-14) and the other that is impermeate to the cell membrane 
(PI). It has been used to assess viability in bull, boar, ram, rabbit, mouse, stallion and human 
spermatozoa. Spermatozoa that stain with SYBR-14 (fluoresce green) are viable, and those 
stained by PI fluoresce red and are non-viable. 
 Evaluation of acrosome status can be performed using flow cytometry on cells 
stained with fluorescein isothiocyanate (FITC) conjugated with either peanut agglutinin (PNA) or 
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Pisum sativum agglutinin (PSA). The PNA lectin is preferred over PSA because its binding is 
more specific, being limited to the outer acrosomal membrane (Cheng et al., 1996). The PNA 
lectin binds to β-galactose moieties of the outer acrosomal membrane of reacted or damaged 
acrosomes; therefore, spermatozoa with non-reacted acrosome will not bind the FITC-PNA 
conjugate (no fluorescence), whereas spermatozoa with a reacted or damaged acrosome will 
bind FITC-PNA conjugate and fluoresce green (Rathi et al., 2001). 
2.5.5. Spermatozoal Chromatin Analysis 
The evaluation of spermatozoal DNA has now become an important test of fertility in 
the stallion. Per cycle pregnancy rates range from 45 to 75%, and despite this very wide range 
in fertility, semen parameters (e.g. motility) can be quite similar between stallions with 
different per-cycle pregnancy rates. The sperm chromatin structure assay (SCSA) test was first 
proposed by Evanson et al., (1980), to measure DNA quality. The SCSA test only evaluates the 
DNA and not the nucleoproteins. The principal of the test uses a metachromatic fluorochrome, 
acridine orange (AO), to evaluate the proportion of single to double stranded DNA present in 
spermatozoa. Acridine orange will fluoresce either red (single-stranded DNA) or green (double-
stranded DNA). Single-stranded DNA is associated with spermatozoa unable to maintain a 
double helix. Either heat or an acid can be used to test the DNA’s ability to maintain a double 
helix. Susceptibility to denaturation is correlated with the level of DNA strand breaks, which can 
be caused by a multitude of factors including idiopathic apoptosis, oxidative stress, heat stress, 
radiation injury, or protamine deficiency. Spermatozoa affected with this type of damage can 
appear normal based on other frequently used laboratory tests, including motility, morphology 












Figure 2.1 Flow cytometric presentation of Sperm Chromatin Structure Assay analysis 
data. Green fluorescence indicates a spermatozoal population with normal undamaged 
chromatin. Red fluorescence represents the cells outside the main population that have 
chromatin damage. 
 
SCSA uses flow cytometry to evaluate fluorescence and the results are depicted in a 
scatter-gram, with green fluorescence on the y-axis and red fluorescence on the x-axis. The 
majority of normal spermatozoa will emit a green fluorescence (main population), and are 
found in the upper left-hand potion of the graph. The damaged spermatozoa will fluoresce red 
and be located outside the main population and along the x-axis. The terms used to describe 
this population of abnormal cells, include the percentage of cells outside the main population 
(COMPαt) and the degree of DNA denaturation (Meanαt) (Figure 2.1). The αt is calculated as the 
ratio of red fluorescence to red and green fluorescence, with the COMPαt and Meanαt values 
calculated from spermatozoal flow cytometric histogram analysis. Love and Kenney (1998) 


















in the absence of other overt reproductive abnormalities and apparent disease, thus 
demonstrating an association between denaturation and reduced fertility. 
 
Table 2.2 The association between DNA denaturation and fertility (Adapted from Love and 
Kenney, 1998). 
Fertility Groups 1 2 3 
Seasonal pregnancy rate 93a 86b 73c 
% Pregnant/cycle 82a 55b 39c 
% Total motile 84a 74b 63c 
% Morphologically normal 69a 46b 46b 
% COMPαt 12
a 17b 25c 
*Superscripts within rows are significantly different (p=0.05) 
 
2.6. Iodixanol 
 2.6.1. Introduction 
Iodixanol (systematic name 5,5’-[(2-hydroxy-1,3-propanediyl)-bis(acetylamino)] 
bis[N,N’-bis(2,3-dihydroxypropyl-2,4,6-triiodo-1,3-benzenedicarboxamide] (Figure 2.2) was 
developed as an imaging contrast agent for radiography.  
It has been evaluated as a contrast agent for endoscopic retrograde 
cholangiopancreatography, cardioangiography, cerebral angiography, urography and aortic 
femoral angiography. It is now used predominately as density gradient for the separation and 
isolation of viable cells (Kjeken et al., 2001), and as a cushion medium for centrifugation. There 
are a number of commercially prepared iodixanol cushion media available (Optiprep™, 
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Accurate Chemical, Westbury, NY; Eqcellsire®Component B, IMV, L’Aigle, France; Cushion 
Fluid  Minitube, Mt Horeb, WI). There is only one preparation with a known percentage of 
iodixanol (Optiprep™, 60% w/v). 
 




2.6.2 Iodixanol as a Contrast Agent 
Iodixanol has a number of chemical properties, including high molecular weight and 
inertness, which suggest it may be safely used with biological material.  Iodixanol is a non-ionic 
dimer, with an osmolarity similar to that of blood (270-320 mOsm/kg). Initial iodinated contrast 
agents had osmolarities 5 to 8 fold greater than blood. Iodixanol is considered a safe contrast 
agent. Iodinated contrast agents are commonly used in human medicine, with up to 70 million 
injections reported worldwide per year (Christiansen, 2004). Iodixanol has become a popular 
contrast agent because it displays a lower incidence of discomfort (heat and pain) compared to 
other iodinated contrast agents after injection. Although rare, the reported side effects include 
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both immediate and delayed reactions to the contrast media in a variety of body systems 
including; cutaneous (erythema); cardiovascular (hypotension, vasodilation, tachycardia, 
cardiac arrest); gastro-intestinal (nausea and vomiting); and respiratory (dyspnea, 
broncospasm, laryngeal edema). The exact pathogenesis of these reactions is unknown, but 
they are typical of hypersensitivity-like reactions, including mast cell and basophil dose 
dependent histamine release (Tumlin et al., 2006). The reported reaction rates for iodixanol 
range from 0.04% for severe reactions to 3% for delayed reactions (ADIS Data Information, 
2006). In a study by Davenport et al., (1999) the toxicity of iodixanol in the lung and its 
absorption from the peritoneal cavity in rabbits was studied. In the lung it was considered a 
good and safe contrast agent because of its isotonicity with  reduced pulmonary edema 
compared to iohexol (another iodinated contrast medium, osmolality 920 mOsm/kg), after 
administration through an endotracheal tube. After intra-peritoneal administration, iodixanol 
was shown to be rapidly absorbed within 1 hour in 89% of treated rabbits, after intra-peritoneal 
administration. Iodixanol is eventually excreted in the urine by glomerular filtration. After 
intravenous injection, 97% of an injected dose is excreted unchanged in the urine after 24 hours 
in healthy patients, and in patients with renal impairment, 8.2% is reportedly recovered in the 
feces (Spencer and Goa, 1996). 
Iodixanol is a large, water-soluble and nonionic molecule, and therefore is not expected 
to pass easily into cells. Kjeken et al., (2001) demonstrated iodixanol uptake by hepatic Kupffer 
cells of rats. Kupffer cells of the liver demonstrate phagocytic activity like macrophage cells, and 
may be more capable of macro-endocytosis as they play an important part in antigen uptake 
and antigen presentation. It is unlikely that spermatozoa are able to take up iodixanol into their 
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intracellular compartment. This is especially unlikely to occur when using freezing extenders 
that have short or no equilibration times. 
2.6.3 Iodixanol and Semen Processing 
Iodixanol was first proposed as a density gradient for the separation of spermatozoa by 
centrifugation, and it has been demonstrated to perform similarly to Percoll (Gellert-Mortimor 
et al., 1988). McCann and Chantler, (2000) compared Percoll and IxaPrep (a polysucrose and an 
iodixanol based density centrifugation preparation, respectively), and evaluated motility, 
spermatozoal longevity, morphology and acrosome reaction. Percoll fractions demonstrated 
higher spermatozoal recovery and better longevity, but there was no significant difference in 
morphology or percent acrosome-reacted cells. In contrast Yang et al., (1998), demonstrated no 
difference in motility and longevity between the two density gradient preparations. 
In a study by Ford et al., (1994), bovine spermatozoa were exposed to 20 to 25% 
iodixanol for one hour without any deterioration in morphology or motility. Harrison, (1997) 
studied the use of iodixanol as a two layer density gradient for the separation of motile human 
spermatozoa by centrifugation. Two layers of iodixanol selected from 25, 35, 40, 45, 50, 60, 70, 
80 and 90% dilutions, were used to separate 25 x 106 progressively motile spermatozoa by 
centrifugation at 400 x g for 15 to 20 minutes. In addition to recovery rates, the toxic effects of 
iodixanol on human spermatozoa and mouse embryos were investigated.  Fresh normal 
spermatozoa, previously separated by 30/45% and 25/40% gradients, were incubated for 72 hr 
before re-evaluating progressive motility. Murine embryos were incubated for 72 hr at 37°C in a 
5% CO2 environment, after 25 µl of 25, 40 or 100% iodixanol was placed below the embryos and 
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culture medium. Results showed that greater than 80% of spermatozoa retained their motility 
and 82 to 86% of embryos developed to the blastocyst stage. There were no controls used in 
this study, but the author concluded these results were satisfactory.  
2.7 Spermatozoal Cushioned Centrifugation 
 The use of fresh cooled or cryopreserved semen is now a mainstay of equine breeding 
programs worldwide. One of the techniques used to process semen for both fresh-cooled 
shipment and cryopreservation is centrifugation. Centrifugation of spermatozoa is performed 
to remove seminal plasma, and replace it with a chilling or freezing extender, as the retention 
of seminal plasma may result in a decrease in fertility for the spermatozoa of some stallions 
(Moore et al., 2005). The properties of an ideal centrifugation protocol are the maximum 
recovery of spermatozoa after centrifugation with minimal spermatozoal damage. The effects 
of centrifugation on equine spermatozoa have been intensively studied, with results reaching 
no definitive conclusion. As a result, centrifugal forces used to process semen are kept 
conservatively low. Forces from 400 to 600 x g are currently considered industry standards 
(Hoogewijs et al., 2011), and it is accepted that losses of up to 25% will occur when diluted 
semen is centrifuged at 400 to 600 x g for 10 to 15 minutes (Loomis & Graham, 2008). Raising 
centrifugation forces to 900 x g has been shown to have no detrimental effect on total and 
progressive motility, viability and acrosome integrity, with a 75% recovery rate of spermatozoa 
reported at 900 x g (Len et al. 2010). 
Another use for iodixanol is cushion-centrifugation. This process involves placing an 
inert, high-molecular weight solution (iodixanol) below the spermatozoa prior to centrifugation 
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to help protect against the mechanical forces that spermatozoa are subjected to during 
centrifugation. The first report of using iodixanol as a cushion for centrifugation of equine 
spermatozoa was by Revell (1997). The use of iodixanol as a centrifugation cushion media has 
now become a popular technique to improve current centrifugation protocols. The current 
popularity of centrifugation cushions is based on reports of higher recovery rates of 
spermatozoa, which subsequently results in more spermatozoa for preservation and larger 
profits for stallion owners. Significantly higher recovery rates of 99-107% for three of four 
treatments (Ecot et al., 2005) and 93% for all cushion treatments (Sieme et al., 2006), have 
been demonstrated when extended spermatozoa are centrifuged at 1000 x g for 20 minutes 
over a cushion, however only one of these studies had similar centrifugation protocols for the 
control samples (Sieme et al., 2006). Despite a difference in centrifugation protocols, Ecot et al., 
(2005) showed a significantly higher number of straws/ejaculate, 72 and 92 straws for 600 x g 
10 mins (control) and 1000 x g 20 mins, respectively, with equivalent pregnancy rates for 
treatments being reported (62.5%). 
After centrifugation, the cushion media must be removed before the addition of further 
semen extenders (Figure 2.3); it is difficult to remove the cushion media without disrupting or 
losing any of the soft spermatozoal pellet.  As a result, erring on the side of caution, the cushion 
is frequently incompletely removed and some unknown percentage of iodixanol residues 
remains. To date only one study (Waite et al., 2009) has demonstrated that the use of iodixanol 
had no deleterious effects on equine spermatozoa, with no reported decrease in spermatozoal 
motility or DNA damage after cushion centrifugation and storage at 4 °C for 24 hour. Saragusty 
et al., (2009) evaluated the effects of incomplete removal of iodixanol during pre-freezing 
29 
 
centrifugation of bull spermatozoa. The investigators hypothesized that iodixanol residues may 
have positive cryoprotective effects, as measured by post-thaw motility, plasma membrane 
functionality and viability, and acrosomal integrity. Their results showed that the presence of 







Figure 2.3 Post-centrifugation pellet and cushion. The supernatant has been removed from the 
conical tubes, and the pellet is the white layer, with the cushion being the clear solution located 
underneath the pellet. These pictures demonstrate before (A) and after (B) iodixanol removal. A 
cushion residue can be seen in the bottom of the tube in B, with the overlying spermatozoal 
pellet. 
 
 The objective of this study was to characterize the effects of iodixanol residues present 
during the cryopreservation of equine spermatozoa. Our hypothesis was that the addition of 
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The objective of this study was to evaluate the effect that 0%, 2.5% and 5% iodixanol 
(v/v; Opitprep™, Accurate Chemical, Westbury, NY; 60% iodixanol w/v) in an egg yolk glycerol-
based freezing extender (EZ Freezin LE, Animal Reproduction Services, Chino, CA) on equine 
spermatozoal total and progressive motility, viability, acrosomal integrity and DNA damage 
after cushion free centrifugation. Our hypothesis was that the addition of iodixanol would 
improve equine spermatozoal post-thaw parameters. 
3.2. Materials and Methods 
Six stallions were used for this study; four were from the LSU Department of Animal 
Sciences, one from the LSU School of Veterinary Medicine teaching herd and one from a client 
of the LSU School of Veterinary Medicine. The stallions ranged from five to 29 years old. Stallion 
semen was collected between August and November in 2010 and 2011. All procedures were in 
accordance (or approved by) the Louisiana State University Institutional Animal Care and Use 
Committee and Clinical Protocols Committee. 
3.2.1. Semen Collection 
 Semen was collected from all stallions at least seven times in an everyday collection 
schedule to deplete the extra-gonadal spermatozoal reserves. After seven consecutive days of 
collection, daily sperm output (DSO) for each stallion had been achieved, as total spermatozoal 
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collected had stabilized, and cryopreservation was performed on the next three ejaculates, 
collected on 24 h intervals.  
 Before semen collection the stallion was teased, until the stallion achieved an erection, 
the penis washed with cotton soaked in warm water to remove smegma, and the excess water 
was removed with a clean towel. Stallions mounted an estral mare or phantom, and semen was 
collected into a Hannover artificial vagina (Animal Reproduction Services, CA), temperature 50-
51 °C. The artificial vagina was equipped with a disposable plastic liner and an in-line nylon 
mesh filter to obtain a gel-free semen sample. After the semen was collected, the filtered 
ejaculate was diluted 1:1 with a milk-based semen extender (EZMixin Original Formula, Animal 
Reproduction Services, CA), which had been warmed to 37° C prior to collection. A 2-ml sample 
of raw semen was saved for later determination of concentration and morphology, and samples 
were transported to the laboratory within 30 min of collection. To account for the variable 
distance of collection facility to the laboratory a mandatory waiting period of 30 minutes was 
applied to all extended samples before centrifugation. During this holding period the extended 
samples were maintained at room temperature in a styrofoam shipping box to protect against 
temperature changes and light exposure. The collected samples were not cooled for 
transportation in this project, as spermatozoal cooling would have resulted in a temporary 
spermatozoal stress which may have had unquantifiable effects on spermatozoal response to 






3.2.2. Semen Processing Overview 
 At the end of the mandatory waiting period, concentration, motility and morphology 
were evaluated by hemacytometer, CASA and wet-mount preparation respectively. The 
treatment groups were 0%, 2.5% and 5% iodixanol (v/v)) in an egg-yolk based extender (EZ 
Freezin LE, Animal Reproduction Services, CA). The calculation of percent iodixanol was based 
on the freezing volume that had a final freezing spermatozoal concentration of 200 x 106/ml. 
3.2.3. Centrifugation 
 The extended semen was divided into three equal volumes prior to freezing, and placed 
in 15-ml conical centrifuge tubes and centrifuged (Eppendorf 5804, Hamburg, Germany)  at 900 
x g for 10 min without a cushion. After centrifugation, the supernatant was removed from each 
tube, leaving approximately 0.5 ml of the supernatant containing the spermatozoal pellet in the 
bottom of the conical tube. Each spermatozoal pellet was then suspended with one of the 
freezing extender/iodixanol preparations, to a freezing concentration of 200 x 106/ml. 
3.2.4. Concentration 
 A 100-µL semen aliquot was diluted into 900 µl of FBS to make a 1:10 dilution. A 100-µl 
aliquot of the 1:10 dilution was further diluted with 900 µl of FBS, making a 1:100 dilution. The 
1:100 dilution was used to fill a Neubauer hemacytometer. The spermatozoal concentration 
was determined by counting all the spermatozoal cell heads within the 25 squares surrounded 
by the triple lines on both sides of the hemacytometer using a phase contrast microscope at 
400x (Olympus BH-2, Olympus America INC., NC). The concentration was the product of the 
average of the number of cells counted on both sides, at 106 per ml. This procedure was 
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performed, and repeated if required, until the difference between the cells counted from both 
sides of the hemacytometer was ≤ 10%. 
3.2.5. Morphology 
 Spermatozoal morphology was assessed with a sample from the 1:10 dilution. A 1-µL 
sample was placed on a plain microscope slide and a coverslip was added. Morphological 
assessment was performed under 1000x oil immersion using phase contrast microscopy 
(Olympus BH-2, Olympus America INC., NC). A total of 100 spermatozoa were counted and 
categorized. 
3.2.6. Cryopreservation  
 After supernatant removal, the spermatozoa were re-suspended with prepared freezing 
extender (EZ-Freezin LE, Animal Reproduction Services, Chino, CA) and iodixanol (Opitprep™, 
Accurate Chemical, Westbury, NY) preparations. Iodixanol was added to the extender (which 
had been thawed at room temperature), with the calculation of the percentage iodixanol being 
based on a final volume that had a freezing concentration of 200 x106/ml. The mixture was then 
inverted repeatedly to ensure complete mixing and distribution. The spermatozoal pellet was 
re-extended to a freezing concentration of 200 x106/ml with the prepared treatment freezing 
extenders. The extended semen was loaded into 0.5-ml straws. For five of the six stallions, 0.5-
ml straws were used but had been reduced in length to contain 0.25-ml of semen, thus allowing 
a reduced volume but maintaining the same straw circumference and dead space. Spermatozoa 
from the sixth stallion were frozen in regular 0.5-ml straws. After the straws were filled, they 
were placed on a styrofoam float, with the straws kept 3 cm above liquid nitrogen. Straws 
remained in the vapor in an enclosed styrofoam box (22 cm x 26.5 cm x 34 cm, 0.198 m3) for 
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ten minutes before being plunged into liquid nitrogen. After cryopreservation straws were 
stored in liquid nitrogen for a minimum of 30 days before post-thaw analysis was performed. 
3.2.7. Motility 
 The spermatozoal motility after collection was analyzed by placing 2 µL of 1:1 extended 
semen in a 20-µm height, four-chambered slide (Leja Products B.V., The Netherlands) over a 
slide warmer at 37°C. The slide was then placed on an optical microscope with a warming stage 
at 37°C (Olympus BX41, Olympus America Inc., NC). Using the 20x phase contrast magnification 
objective, spermatozoal motility was analyzed program with a computer assisted sperm 
analysis program (Sperm Vision® 3.0, Minitube, Verona, WI). Spermatozoa were identified 
based on defined parameters (Appendix A), and before final values were stored each recorded 
clip was edited and all non-spermatozoal events (e.g. egg-yolk particles) were removed. Mean 
percentages of total and progressive motility were assessed from seven fields with a minimum 
of 100 spermatozoa in each field. 
 Motility analysis prior to cryopreservation was performed on each treatment. A 100-µL 
aliquot of each treatment (0%, 2.5% and 5%) was collected before straw-filling, placed in a 
micro-centrifuge tube, and diluted with 400 µL of centrifuge extender to a final concentration 
of 40 x 106/ml for motility analysis. Post-thaw analysis was performed after thawing samples in 
a 37°C water bath for thirty seconds. A similar dilution from a sample of thawed semen as 
described above was used. Total and progressive motility analysis was performed at 5 and 30 





3.2.8. Plasma Membrane Integrity 
 The fluorescent dyes Propidium Iodide (PI) and SYBR-14 (Molecular Probes Inc., Eugene, 
OR) were used to assess plasma membrane integrity. Both are nucleic acid fluorescent dyes; 
SYBR-14 is able to cross an intact plasma membrane staining the spermatozoa green, and PI is 
only able to cross a disrupted membrane causing the spermatozoa to stain red. Therefore green 
spermatozoa are considered viable, and red-stained spermatozoa are considered non-viable or 
dead. 
 A 1-µL aliquot from each of the treatment groups was stained to assess the plasma 
membrane integrity, by dilution with 200 µL of PBS (pH 7.4 and 320 mOsm) to a final 
concentration of 1 x 106/ml. Cells were then initially stained with 2-µL of SYBR-14 and incubated 
at 37°C for 10 min in the dark. After incubation, 2-µL of PI was added and incubation continued 
for a further 10 min before flow cytometric analysis. A triplicate preparation of each treatment 
was made for flow cytometric analysis. 
 Stained samples were kept in the dark and analyzed with a flow cytometer (C6 Flow 
Cytometer, Accuri Cytometer, Ann Arbor, MI) and kept dark until analysis. The flow rate of cells 
was set at 100 to 200 cells/sec. Cells were gated to exclude debris based on side-scatter and 
forward-scatter characteristics using a dot plot (Appendix B.1). The gated population was then 
subjected to green and red light with spermatozoal fluorescence allowing the separation of 
spermatozoa from non-spermatozoal events, and viable from non-viable spermatozoa, and 





3.2.9. Acrosome Reactivity 
 A separate 1-µL aliquot of each treatment was stained to assess the change in acrosome 
reactivity before and after cryopreservation for each treatment. Acrosome reactivity was 
measured by dual staining spermatozoa with a combination of fluorescein-conjugated Arachis 
Hypogaea agglutinan (FITC-PNA) and PI. Fluorescein-conjugated Arachis Hypogaea agglutinan 
binds to the β-galactose moieties of the outer acrosomal membrane and fluoresces green. The 
PI was used to differentiate viable from non-viable spermatozoa. 
 The 1-µL aliquot was initially diluted with 200 µl of PBS to a concentration of 1 x 106/ml. 
Cells were stained first with 2 µL FITC-PNA, incubated at 37°C for 10 min in the dark, then 2 µL 
of PI was added, and incubated for a further 10 minutes before analysis by flow cytometry, at a 
flow rate of 100 to 200 cells/sec. A triplicate preparation of each treatment was made for flow 
cytometric analysis, and all samples were stored in the dark until analysis. 
 Stained samples were then analyzed with a flow cytometer (C6 Flow Cytometer, Accuri 
Cytometer, Ann Arbor, MI) using quadratic gating (Appendix B.3). Cells were initially gated to 
exclude debris based on side-scatter and forward-scatter characteristics using a dot plot, and 
florescence analysis was subsequently performed on eleven thousand events, which were 
quadrant gated. Spermatozoa were analyzed as four groups, viable spermatozoa non-reacted 
acrosome, viable spermatozoa reacted acrosome, non-viable spermatozoa non-reacted 
acrosome and non-viable spermatozoa reacted acrosome (CFlowPlus software, Accuri 





3.2.10. Sperm Chromatin Structure Assay 
Sample collection for SCSA was performed immediately after the addition of the 
prepared freezing treatments. A 0.5-ml aliquot from each of the freezing extender treatments 
was placed in 1.0-ml cryovials (Sigma-Aldrich©, St. Louis, MO), and snap-frozen in liquid 
nitrogen (LN). Samples were stored in LN for at least 30 days before analysis. 
 Individual samples were thawed in a 37°C water bath. Aliquots of approx 2-µl of thawed 
semen were mixed with 198 µl of a buffered isotonic solution (0.186 g disodium EDTA, 0.79 g 
Tris-HCL, 4.38 g NaCl, in 500 ml deionized water, pH 7.4). Samples were then combined with 
400 µl of a detergent solution (pH 1.2; 2.19 g NaCl, 1.0 ml of 2 M HCL, 0.25 ml Triton-X, qs. 250 
ml deionized water) for 30 sec, and then 1.2 ml of acridine orange solution (3.8869 g citric acid 
monohydrate, 8.9429 Na2HPO4, 4.385 g NaCl, 0.17 disodium EDTA,  4.0 µg/ml acridine orange 
stock solution (1 mg/ml), qs. 500 ml water, pH 6.0) was added to the sample, and processed 
immediately (30 sec) on a flow cytometer (FACScan; Becton Dickinson, Mountain View, CA). 
After 30 sec, 11000 events were recorded for analysis, at a flow rate of 100 to 200 cells/sec. 
During preparation and evaluation of individual samples, the buffered solution, detergent 
solution and acridine orange solutions were all kept in an ice bath, and all sample handling was 
performed in a darkened room. 
3.2.11. Extender Osmolality 
 The extender osmolality after addition of iodixanol was measured using a vapor 
pressure osmometer (VAPRO 5520, VAPRO® WESCOR, Logan, UTSolutions of 0%, 2.5% and 5% 
iodixanol in freezing extender (v/v) solutions were prepared. A 10-µL sample of each 
preparation to be tested was aspirated and inoculated onto a solute free paper disc. The 
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inoculated disc was then inserted and locked into the sample chamber and the osmolality 
measured. Samples were measured in duplicate, with the mean value recorded. 
3.2.12. Statistical Analyses 
 The mean (± S.E.) percentage pre- and post-thaw total motility, progressive motility, 
viability, acrosome reactivity, COMPαt and MEANαt were analyzed using the Shapiro Wilk’s test 
to evaluate if data followed a normal distribution. The only parameter that followed a normal 
distribution was MEANαt and an ANOVA was performed and where a significant interaction of 
treatment was observed (p<0.05), a Tukey-Kramer post-hoc test was applied. For measured 
parameters that did not follow a normal distribution, a binomial logistical regression was 
performed using spermatozoal (events and trials) numbers for each measured parameter 
(Appendix C), and results are presented in percentage. Where a significant interaction of 
treatment was observed (p<0.05), a Tukey-Kramer post-hoc test was applied. All statistical 
analysis was performed using statistical analysis software (SAS 9.3, SAS Institute Inc, Cary, NC). 
3.3. Results 
Total motility results did not follow a normal distribution and therefore a binomial 
logistic regression was performed (Appendix C.1). The 0% post-thaw TM was found to be 
significantly higher than that of 2.5% iodixanol treatment, and neither 0% or 2.5% treatment 
groups were significantly different from the 5% treatment group. There was a significant 






Table 3.1 Mean (±SE) spermatozoal total motility (TM) percentage (%) pre- and post-
cryopreservation (n=6) with 0%, 2.5% and 5% iodixanol (v/v) in freezing extender. 
Treatment Pre-Freeze TM (%) Post-Thaw TM (%) 
0 % Iodixanol 65.16 ± 3.28%a1 31.93 ± 3.1%a2 
2.5 % Iodixanol 64.65 ± 3.3%a1 28.1 ± 2.9 %b2 
5 % Iodixanol 64.14 ± 3.3%a1 30.4 ± 3.1%ab2 
Values within column with different letter subscript are significantly different (P<0.001). 
Values within rows with different number subscript are significantly different (P<0.001). 
 
 Progressive motility results did not follow a normal distribution and was analyzed using 
a binomial logistic regression (Appendix C.2). The 0% post-thaw PM was found to be 
significantly higher than 2.5% iodixanol treatment, and neither 0% or 2.5% treatment groups 
were significantly different from the 5% treatment group. There was a significant difference 
between pre- and post-cryopreservation PM. There was a significant difference between pre- 
and post-cryopreservation PM for all treatment groups (Table 3.2). 
 
Table 3.2 Mean (±SE) spermatozoal progressive motility (PM) percentage (%) before and after 
cryopreservation (n=6) with 0%, 2.5% and 5% iodixanol (v/v) in freezing extender. 
Treatment Pre-Freeze PM (%) Post-Thaw PM (%) 
0% Iodixanol 53.75 ± 4.44%a1 23.72 ± 3.23%a2 
2.5% Iodixanol 53.44 ± 4.44%a1 20.19 ± 2.87%b2 
5% Iodixanol 52.5 ± 4.44%a1 21.94 ± 3.04%ab2 
Values within column with different letter subscript are significantly different (P<0.001). 




 Thirty minute post-thaw TM results did not follow a normal distribution and was 
analyzed by a binomial logistic regression (Appendix C.3). The 2.5% post-thaw TM was found to 
be significantly lower than the 0% and 5% iodixanol treatment groups, and neither 0% nor 5% 
treatment groups were significantly different (Table 3.3). 
 
Table 3.3 Mean (±SE) spermatozoal thirty minute post-thaw TM percentage (%) after 
cryopreservation (n=6) with 0%, 2.5% and 5% iodixanol (v/v) in freezing extender. 
Treatment 
Thirty Minute Post-thaw Total 
Motility (%) 
0% Iodixanol 40.25 ± 3.52%a 
2.5% Iodixanol 36.77 ± 3.41%b 
5% Iodixanol 39.53 ± 3.49%a 
Values within column with different letter subscript are significantly different (P<0.001). 
  
Thirty minute post-thaw PM results did not follow a normal distribution and was 
analyzed by a binomial logistic regression (Appendix C.4). The 2.5% post-thaw PM was found to 
be significantly lower than the 0% and 5% iodixanol treatment groups, and neither 0% nor 5% 









Table 3.4 Mean (±SE) spermatozoal thirty minute post-thaw PM percentage (%) after 
cryopreservation (n=6) with 0%, 2.5% and 5% iodixanol (v/v) in freezing extender. 
Treatment 
Thirty Minute Post-thaw 
Progressive Motility (%) 
0% Iodixanol 30.41 ± 3.87%a 
2.5% Iodixanol 27.17 ± 3.62%b 
5% Iodixanol 28.94 ± 3.76%a 
Values within column with different letter subscript are significantly different (P<0.001). 
 
Post-thaw spermatozoal viability results did not follow a normal distribution and was 
analyzed using a binomial logistic regression (Appendix C.5). The 5% post-thaw viability was 
significantly greater than both the 0% and 2.5%, with the 2.5% being significantly higher than 
the 0% treatment group in post-thaw analysis; however, the pre-freeze 2.5% treatment group 
had significantly less spermatozoal viability prior to freezing than the 0% and the 5% treatment 
groups. There was a significant difference between pre- and post-cryopreservation 










Table 3.5 Mean (±SE) spermatozoal viability percentage (%) before and after cryopreservation 
(n=6) with 0%, 2.5% and 5% iodixanol (v/v) in freezing extender. 
Treatment Pre-Freeze Viability (%) Post-Thaw Viability (%) 
0% Iodixanol 59.88 ± 6.72%a1 22.97 ± 4.95%a2 
2.5% Iodixanol 59.07 ± 6.77%b1 24.14 ± 5.13%b2 
5% Iodixanol 62.24 ± 6.57%c1 24.81 ± 5.22%c2 
Values within column with different letter subscript are significantly different (P<0.001). 
Values within rows with different number subscript are significantly different (P<0.001). 
 
 Post-thaw results for damaged or reacted acrosomes did not follow a normal 
distribution and was analyzed using a binomial logistic regression (Appendix C.6). Results 
showed significantly less reacted or damaged acrosomes for the 0% post-thaw treatment group 
compared to the 2.5% and 5% groups, with the 2.5% group having significantly less reacted or 
damaged acrosome than the 5% group. There was a significant difference between pre- and 
post-cryopreservation acrosome reactivity for all treatment groups, with the 5% pre-freeze 
having significantly fewer reacted or damaged spermatozoa than 0% or 2.5%, and then having a 
post-thaw value showing significantly more reacted or damaged acrosomes than he 0% or 2.5% 








Table 3.6 Mean (±SE) acrosome reactivity percentage (%) before and after cryopreservation 
(n=6) with 0%, 2.5% and 5% iodixanol (v/v) in freezing extender. 
Treatment Pre-Freeze Reacted (%) Post-Thaw Reacted (%) 
0% Iodixanol 8.92 ± 1.27%a1 12.88 ± 1.75%a2 
2.5% Iodixanol 8.12 ± 1.17%b1 13.5 ± 1.83%b2 
5% Iodixanol 7.8 ± 1.13%c1 14 ± 1.13%c2 
Values within column with different letter subscript are significantly different (P<0.001). 
Values within rows with different number subscript are significantly different (P<0.001). 
 
 The post-thaw COMPαt results did not follow a normal distribution and was analyzed 
using a binomial logistic regression (Appendix C.7). Pre- and post-thaw results showed 
significantly less COMPαt as iodixanol was added. Post-thaw results showed 5% iodixanol 
treatment group having significantly better COMPαt than both the 0% and 2.5% groups, with the 
2.5% group having significantly better COMPαt than the 0% group post-cryopreservation. Except 
for the 0% treatment group, there was a significant difference between pre- and post- 
cryopreservation chromatin denaturation (Table 3.7).  
Table 3.7 Mean (±SE) COMPαt (%) before and after cryopreservation (n=6) with 0%, 2.5% and 
5% iodixanol (v/v) in freezing extender. 
Treatment Pre-Freeze COMPαt (%) Post-Thaw COMPαt (%) 
0% Iodixanol 16.24 ± 1.05a1 16.75 ± 1.07a1 
2.5% Iodixanol 13.28 ± 0.88b1 15.02 ± 0.98b2 
5% Iodixanol 14.6 ± 0.96c1 13.8 ± 0.92c2 
Values within column with different letter subscript are significantly different (P<0.001). 
Values within rows with different number subscripts are significantly different (P<0.001). 
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 The MEANαt results were normally distributed and an ANOVA was performed. There was 
no significant difference either between pre- and post-cryopreservation, or between treatment 
groups (Table 3.8). 
 
Table 3.8 Mean (±SE) MEANαt (%) before and after cryopreservation (n=6) with 0%, 2.5% and 
5% iodixanol (v/v) in freezing extender. 
Treatment Pre-Freeze MEANαt (%) Post-Thaw MEANαt (%) 
0% Iodixanol 220.91  ± 4.77%a1 223.12 ± 2.41%a2 
2.5% Iodixanol 218.08 ± 4.77%a1 224.7 ± 2.52%a2 
5% Iodixanol 218.89 ± 4.77%a1 223.6 ± 2.42%a2 
Values within column with different letter subscripts are significantly different (P=0.05). 
Values within rows with different number subscripts are significantly different (P=0.05). 
 
 Measurement of the osmolality for each treatment group freezing extender 
combination showed that with increasing concentrations of iodixanol, extender osmolality 





Figure 3.1 Mean treatment iodixanol in extender osmolality measurement with 0%, 2.5% and 
5% iodixanol (v/v) in freezing extender. 
 
3.4. Discussion 
 In this experiment, the semen from five of the six stallions was cryopreserved in 0.5-ml 
straws that had been shortened to a capacity of 0.25-ml. This reduction in straw length was 
performed because the stallions at DSO were not producing enough spermatozoa to allow 
sufficient samples to be collected in 0.5-ml straws. Whether such low sperm output was due to 
normal stallion production, or if there was a seasonal effect could not be determined as the 
DSO for these stallions during the physiological breeding season had not been previously 
determined. Based on a constant external surface area, the thermodynamic changes of either a 
0.5-ml straw or a 0.5-ml straw reduced in length should not differ as both types have a similar 
straw circumference. Both 0.5-ml and 0.25-ml straws have been used for cryopreservation in 














motility, intact plasma membranes or intact acrosomal membrane has been demonstrated 
when semen was frozen in 0.25-ml or 0.5-ml straws (Nascimento et al., 2008). Additionally the 
freezing concentration of 200 x 106/ml (used in this study) has been demonstrated to have 
superior total and progressive post-thaw motility than semen frozen and stored in 0.5-ml 
straws at 400 x 106 or 800 x 106 /ml when cryopreserved in an egg-yolk based extender (Loomis 
and Clark 1998). As a result, if the freezing concentration for each stallion in this experiment 
was maintained at 200 x 106/ml in 0.5-ml straws, it is unlikely that there would have been an 
effect of straw length exerted on spermatozoa during cryopreservation.  
A lactose-egg yolk-glycerol extender (EZ-Freezin LE), was selected for this study because 
a period of refrigeration to allow spermatozoa to equilibrate at 4 °C prior to freezing is not 
required. As per the manufacturer’s instructions the extender is kept frozen, and allowed to 
thaw to 22 °C before extension of the semen. Heitland et al., (1996) demonstrated that a 
prolonged pre-freeze cooling was not required for lactose egg-yolk extended spermatozoa. 
Stallion spermatozoa are particularly susceptible to damage from 20°C to 5°C when a rapid 
cooling rate is used, which can result in disruption of the plasma membrane integrity and 
function due to phase transition of phospholipids, alterations in water transport properties 
(Devriddy et al., 2002), and physical disruption of spermatozoal plasma and acrosome 
membranes (Watson et al., 1987). The exact mechanism of action of egg-yolk is still unknown; 
however, it is proposed that the low density lipoproteins (LDL) stabilize the plasma membrane 
and forming a protective film around the sperm membrane (Sieme, 2010). Our results 
demonstrate that as the percentage of iodixanol increased spermatozoal viability increased. 
Iodixanol is a large inert molecule that unlike the egg-yolk LDLs, may not interact with the 
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plasma membrane, but the presence of iodixanol may alter the shape of unfrozen channels 
present as water crystalizes with falling temperatures. The main disadvantage of using an egg-
yolk diluent is the opaqueness of egg-yolk particles, which results in significant debris requiring 
manual removal from CASA analysis. Egg-yolk particles were also responsible for a large 
proportion of the recorded events using flow cytometry due to similar side-scatter and forward-
scatter characteristics as spermatozoa. 
Reducing the effects of osmotic stress is an important method of improving both post-
thaw values and also fertilization rates. Osmolality measurement in this study showed that as 
Optiprep™ concentration increased, total freezing extender osmolality decreased. This may 
partially explain the significantly higher spermatozoal plasma membrane integrity as shown in 
this study. Pommer et al., (2002) demonstrated that when spermatozoa were exposed to 900 
mOsm/kg, and subsequently returned to isosmolal conditions (300 mOsm/kg), there was a 
lower number of viable spermatozoa present than control spermatozoa maintained at 300 
mOSm/kg; and that spermatozoa failed to return to pre-treatment levels of motility if 
incubated in a solution in excess of 450 mOsm/kg. Although all treatment extenders were in 
excess of 900 mOsm/kg in our study, the addition of Optiprep™ resulted in a decrease in 
osmolality, this slight decrease in osmolality may explain why there were significantly more 
viable spermatozoa present after cryopreservation in the 2.5% and 5% treatment groups 
compared to the 0% treatment group. 
The presence of iodixanol may alter the formation of extracellular ice crystals during 
cryopreservation. As temperatures drop, water crystalizes, leaving solutes and spermatozoa in 
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unfrozen channels. The presence of large iodixanol molecules may alter the shape of these 
channels. Saragusty et al., (2009) showed a positive effect of iodixanol on both spermatozoal 
motility and acrosomal reactivity, and increasing the percentage of iodixanol altered extra-
cellular ice crystal shape and organization (Figure 5). It was noted that a 60% iodixanol (w/v; 
Optiprep™) produced fine grainy crystals, while a 2.5 and 5% iodixanol in Andromed® 
preparation produced ice crystal dendrites that were tight and well organized. The 2.5%  
 
Figure 3.2 From Saragusty et al., (2009). Directional cryo-microscopy of A) Phosphate Buffered 
Saline B) 2.5% Optiprep™ in Andromed® C) Andromed® D) 5% Optiprep™ in Andromed® E) 
Optiprep™ F) 50% Optiprep™ in Andromed®. 
 
iodixanol had an average intra-dendritic width of 8.71 ± 4.03 µm. The authors suggest that 






equine spermatozoal head length is 3 to 4 µm. Below 2.5% iodixanol it was noted the ice crystal 
dendrites were looser and less well organized. This hypothesis may help to explain the higher 
percentage of viable spermatozoa when 5% iodixanol was used in the present study. 
 We showed that there was significantly less damaged DNA when iodixanol was added. It 
is unlikely that iodixanol is membrane permeable or acquired by endocytosis; therefore the 
protective effect of iodixanol on DNA must come from either alteration of ice crystal dendrites 
(Saragusty et al., 2009), or protection of plasma membranes by reducing osmotic stress.  
Reduced plasma membrane damage, as shown in our study, may prevent entry of calcium ions 
that have been shown to be associated with activation of the intrinsic apoptotic pathways in 
spermatozoa (Watson 2000). In addition, an overall decrease in non-viable cells should result in 
decreased ROS production; ROS has been shown to cause increase DNA fragmentation 
(Baumber et al., 2003). It was noted during analysis that the 5% treatment group COMPαt pre-
freeze value was 14.6 ± 0.96% and post-thaw was 13.8 ± 0.92%. This would suggest that 
chromatin integrity improved with cryopreservation. The analysis and gating of flow cytometry 
results were performed by a single experienced operator, to reduce operator-induced gating 
differences. The presence of egg-yolk particles being counted during analysis may have falsely 
increased COMPαt results. 
 If iodixanol has a protective effect, before it can be included in commercially available 
freezing extenders in vivo studies need to be performed to examine what effects iodixanol 
might have on the endometrium and potential pregnancy in the horse. To date no such studies 
have been performed in the horse. There are limited in vitro studies examining the effect of 
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iodixanol on reproductive systems in any species. A study by Heglund et al., (1995) examined 
the reproductive toxicology of the daily administration of intravenous iodixanol to both male 
and female mice. Female rats (n=30) received 0, 1 or 2 grams iodixanol/kg, beginning 15 days 
before initiation of a 14-day cohabitation period with untreated males, with treatments 
continuing until either euthanasia at day 20 of presumed gestation or until day 21 post-partum. 
Male mice were treated with similar dosages from nine weeks prior to mating, through mating, 
and then until day 20 of presumed gestation. In both experiments treatment with iodixanol 
showed no effect on cycle length, mating performance, pregnancy rate, copulation, litter size 
and mean fetal weight. The only abnormalities noted were some transient changes in body 















The utilization of centrifugation cushions has become a popular technique used in 
equine practice for the handling and preparation of semen. Its use has been promoted by 
numerous positive studies demonstrating increased spermatozoal recovery rates, without any 
increase in spermatozoal damage, thereby making semen centrifugation a more efficient 
process. Centrifugation cushions are marketed as allowing increased numbers of mares to be 
bred, with resulting increased profits for stallion owners. As a result there are now a number of 
iodixanol-based products commercially available, with only one product (Optiprep™) that has a 
known iodixanol percentage included in the manufacturer’s data sheet. Despite the increasing 
use of iodixanol, to date there has been no equine safety study examining the effect iodixanol 
will have on the outcome of semen quality when present during cryopreservation. The amount 
of cushion media required varies from 30 µL to 3 ml, depending on what centrifugation vessel is 
used and manufacturer’s instructions, but all techniques will result in an iodixanol residue being 
retained with the semen during further processing. The attempted recovery of all iodixanol is 
hindered by the resultant soft spermatozoal pellet that rests on the cushion after 
centrifugation. During the recovery process there is a point where retrieving the iodixanol must 
be stopped as it may compromise spermatozoa recovery, with a result that not all iodixanol is 
recovered.  
There were a number of problems encountered in this study. These included stallion 
number and location, and the collection of samples outside the normal physiological breeding 
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season for a stallion. There were limited numbers of stallion available for this study and the 
stallions used were located within a 15 mile radius of the laboratory. To account for the 
handling time, a standard 30 min period was established when the semen was extended and 
kept in a styrofoam box to help negate the effects of storage temperature. The age range of the 
stallions used was from 5 to 29 years, with an age difference of 16 years between the oldest 
and next oldest stallion. Ideally this study should have been performed during the normal 
physiological breeding season. Whether there was an effect of season is difficult to establish as 
there were no previous semen analysis records available for five of the stallions in this study.  
The results of significantly higher plasma membrane integrity as demonstrated in this 
study, before and after freezing, with the addition of iodixanol are consistent with the decrease 
in freezing extender osmolality as iodixanol percentage is increased. This would suggest a 
possible protective mechanism of iodixanol is prevention of osmotic damage to spermatozoal 
plasma membranes during cryopreservation. This protective effect may occur either after the 
addition of the freezing extender to the spermatozoa, as the glycerol equilibrates across the 
plasma membrane or during thawing, when spermatozoa are exposed to a transient hypo-
osmotic environment. The subsequent retention of an intact plasma membrane will result in 
maintaining DNA integrity, as the intact membrane will help prevent apoptotic changes and 
formation of ROS which are associated with increased DNA damage. Whether the presence of 
large iodixanol molecules create similar spermatozoal-friendly channels for spermatozoa during 
freezing, and alter ice crystal formation as shown in a study of bovine cryopreservation 
(Saragusty et al. 2009) needs to be demonstrated. A positive cryoprotective effect is suggested 
as the 2.5% treatment group had significantly lower pre-freeze plasma membrane integrity, but 
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after cryopreservation it had a significantly higher integrity than the 0% treatment group. In 
contrast acrosome integrity after cryopreservation deteriorated with the addition of iodixanol, 
suggesting that the presence of iodixanol is detrimental to the acrosome’s ability to survive 
freezing. This is an unusual finding as the anatomic location of the acrosome in the 
spermatozoal head means it is surrounded by a cellular cytoskeleton which would make the 
acrosome better protected from the effects of osmotic stress, and suggests whatever plasma 
membrane damage that is occurring is regionally located to the spermatozoal head, and the 
underlying acrosome. 
In conclusion, although this study showed some significant differences of treatment for 
total and progressive motility, plasma membrane integrity, acrosomal integrity and DNA 
damage, it may be difficult to demonstrate any clinical importance of these changes. A fertility 
trial would be the ultimate test to evaluate the effects of iodixanol. The hypothesis of this study 
was that the presence of iodixanol would have positive cryoprotective effects, and these results 
show that the addition of 2.5% or 5% iodixanol may have some significant cryoprotective 
properties. In addition, this study has answered an important question posed frequently by 
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THE CASA SPERM VISION® 3.0. PARAMETERS USED FOR EQUINE SPERMATOZOAL ANALYSIS 
 20µM field of view depth 
 Cell identification: 14 to 80µM2 
 500 cells or 7 fields 
 Immotile: AOC < 9.5 
 Local motile: DSL < 6 
o Hyper-active= VCL > 80, LIN < 0.65, ALH > 6.5 
o Linear= STR > 0.9, LIN > 0.5 
o Non-linear= STR < 0.9, LIN < 0.5 
o Curvilinear= DAP/radius ≥ 3 & LIN < 0.5 
 
 









FLOW CYTOMETRIC GATING 
Appendix B.1 An example of flow cytometric analysis (CFlowPlus Software , Accuri Cytometer, 
Ann Arbor, MI). The distribution of recorded events based on side-scatter and forward-scatter 

















Appendix B.2 Scatter dot plot of a viability stained equine semen sample analyzed with a flow 
cytometer (CFlowPlus Software , Accuri Cytometer, Ann Arbor, MI). Axis are described as FL3-A 





















APPENDIX B.3 Scatter plot of an acrosome integrity stained equine semen sample analyzed 
with a flow cytometer. Quadratic gating was used to analyze the cell population (CFlowPlus 
Software, Accuri Cytometer, Ann Arbor, MI). Upper left (UL), dead-nonreacted acrosome; upper 
right (UR), dead-reacted acrosome; lower left (LL), viable-nonreacted acrosome; lower right 





















EVENTS AND TRIALS USED FOR BINOMIAL LOGISTIC REGRESSION 
Appendix C.1 The total events and trials used for the binomial logistic regression for total 
motility pre-cryopreservation. 
 
0% Iodixanol 2.50% Iodixanol 5% Iodixanol 
Events 4695 4342 4096 
Trials 7263 6792 6466 
 
Appendix C.2 The total events and trials used for the binomial logistic regression for 
progressive motility pre-cryopreservation. 
 
0% Iodixanol 2.50% Iodixanol 5% Iodixanol 
Events 3594 3594 3375 
Trials 7263 6792 6466 
 
Appendix C.3 The total events and trials used for the binomial logistic regression for total 
motility at 5 and 30 mins post-thaw. 
  
0% Iodixanol 2.50% Iodixanol 5% Iodixanol 
5 min Post-
thaw 
Events 1900 1742 1913 
Trials 5911 6160 6256 
30 min Post-
thaw 
Events 1648 1464 1614 





Appendix C.4 The total events and trials used for the binomial logistic regression for 
progressive motility at 5 and 30 mins post-thaw. 
  
0% Iodixanol 2.50% Iodixanol 5% Iodixanol 
5 min Post-
thaw 
Events 1453 1287 1425 
Trials 5911 6160 6256 
30 min Post-
thaw 
Events 1208 1045 1183 
Trials 5911 6160 6256 
 
Appendix C.5 The total events and trials used for the binomial logistic regression for 
spermatozoal viability pre-cryopreservation and post-thaw. 
  
0% Iodixanol 2.50% Iodixanol 5% Iodixanol 
Pre-
cryopreservation 
Viable 209410 209078 233270 
Non-viable 139426 141610 137165 
Trials 348836 350688 370435 
Post-thaw 
Viable 69698 71336 70203 
Non-viable 203295 195152 188800 










Appendix C.6 The total events and trials used for the binomial logistic regression for 
spermatozoal acrosomal integrity pre- and post-cryopreservation. 
  









48119 43778 42076 








72558 75916 79260 
Trials 540939 540652 540910 
 
Appendix C.7 The total events and trials used for the binomial logistic regression of COMPαt.  
  
0% Iodixanol 2.50% Iodixanol 5% Iodixanol 
Pre-
cryopreservation 
Events 12736 10300 11573 
Trials 77174 76522 78159 
Post-thaw 
Events 13057 11729 10724 
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